Sangamo Forum: Pipeline Links
Marty Chilberg's Blog
2.67K Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
Summary
- The Bridge and Tunnel investor forum can be a little hard to navigate.
- The following links are useful to find content topically.
| Sangamo Forum Hotlinks | Forum | Govt | ||||
| Gene Editing/Therapy group | Group Home | |||||
| Home Page | Home | |||||
| Analysts | Index | |||||
| Company/Financial | Index | |||||
| Employees | Index | |||||
| Pipeline & Products | Index | |||||
| CNS | Index | |||||
| ALS/FTLD | C90RF72 ZFP-TF | |||||
| Huntington's (shire) | HD | |||||
| Tau reduction | Tauopathy | |||||
| Hematology | Index | |||||
| Beta-Thal | BIVV collab | ST-400 | ||||
| HemoA | Alta | SB-525 | ||||
| HemoB | FIXtendz | SB-FIX | ||||
| Sickle Cell | BIVV-003 | |||||
| Immunology | Index | |||||
| HIV | HIV | SB-728-HSPC | ||||
| HIV-Case | CCR5 KO Case | |||||
| Inherited Metabolic | Index | |||||
| Fabry | ST-920 | |||||
| MPS I | Empowers | SB-318 | ||||
| MPS II | Champions | SB-913 | ||||
| Gene Reg platform | ZFP-TF | |||||
| Molecular Eng | Index | |||||
| Agriculture | Index | |||||
| Oncology | Index | |||||
| Universal T Cells | Universal Tcells | |||||
| Gilead/Kite | CAR, TCR, NKR | |||||
| Transgenic Animals | Index | |||||
| IVPRP platform | IVPRP | |||||
| Lentiviral Vector | IDLV | |||||
| Adeno Associated | AAV | |||||
| Lipid Nanoparticles | LNP | |||||
| Improving Delivery | GE Delivery | |||||
| Blog articles | List | |||||
| Message Board | ||||||
| InvestorVillage | Link | |||||
Analyst's Disclosure: I am/we are long SGMO.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.